A major new study reveals that nearly half of young children diagnosed with ADHD receive medication within just one month of diagnosis, even though pediatric guidelines recommend starting with behavioral therapy first for this age group.
The largest study of its kind examined electronic health records from more than 712,000 children seen at eight major pediatric health systems across the United States between 2016 and 2023. Among the 9,708 children who received an ADHD diagnosis between ages 4 and 5, over two-thirds were ultimately prescribed medication before turning 7.
Why Guidelines Recommend Therapy First
ADHD affects an estimated 10% of American children, and diagnoses in preschoolers are becoming more common. A 2022 national survey found that 2.4% of children aged 3 to 5 had an ADHD diagnosis.
Current American Academy of Pediatrics (AAP) guidelines, reaffirmed in 2019, recommend that children aged 4 to 5 first receive evidence-based parent training in behavior management before considering medication. Medication should be considered only if these interventions prove insufficient or if symptoms cause substantial disruption.
Yet across the eight health systems studied, between 26% and 49% of preschoolers were prescribed medication within a month of diagnosis, often leaving little or no time for behavioral treatments to take effect.
The AAP recommendations exist because preschoolers’ brains are still rapidly developing, and the evidence base for behavioral interventions is stronger in this age group than for medication. Parent training helps caregivers manage challenging behaviors, establish routines, and create structured environments that can meaningfully reduce ADHD symptoms.
For children who were prescribed medication within 30 days, there often wasn’t enough time to properly implement or assess these therapies, which typically require weeks or months to show benefit.
Racial and Insurance Disparities in ADHD Treatment
The study revealed clear disparities. Asian children with ADHD were least likely to receive early medication, with only 28.6% prescribed within 30 days, compared to 43.9% of White children. Hispanic children were at 35.8%, Black children 41.8%, and multiracial children the highest at 47.7%.
These gaps persisted two years after diagnosis. White children had prescription rates of 78.2%, while Asian children had substantially lower rates at 55.6%.
Publicly insured children were more likely to receive early prescriptions than privately insured peers. Families on Medicaid often face barriers accessing behavioral therapy, making medication the more immediate option. Prior research suggests that minority families may have greater hesitancy toward ADHD medication, but also encounter obstacles to behavioral care.
Preschool ADHD Care Varies Widely
Prescription rates varied dramatically across the eight health systems, from 44.1% to 74.1%. This suggests that treatment decisions may depend as much on geography and local resources as on clinical guidelines.
Older preschoolers were more likely to receive medication quickly. The median time to prescription was zero days for 5-year-olds, compared to nearly 400 days for 3-year-olds.
Comorbidities played a role too. Children with sleep problems or disruptive behavior disorders were more likely to get early medication. About 65% of children had a documented additional condition, such as language delays or learning difficulties.
Follow-up care was inconsistent. Only about 40% of children prescribed medication had a documented follow-up within two months, though the true number may be higher since many doctors use phone calls or secure messaging not captured in records.
A System Under Strain
The study exposes how practical realities often drive treatment. Behavioral therapies require trained providers, multiple sessions, and significant family commitment. In many communities, especially for families with public insurance, such resources are scarce.
Primary care doctors face heavy caseloads and limited access to mental health specialists. Writing a prescription takes minutes, while arranging therapy can take hours, with no guarantee that services are available.
The results don’t mean early prescriptions are always inappropriate. Some children may genuinely need immediate medication, especially with severe symptoms or multiple conditions. But the scale of early prescribing points to a startling gap between recommended best practice and what families actually experience.
Source : https://studyfinds.org/doctors-often-prescribe-adhd-meds-preschoolers-without-delay/
